Physician profile
Jack Lee
NPI 1538653217
$920.22
in general payments reported to CMS, 2019-2025
16 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $185 · 2024: $312 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.27 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $277.38 | 2023-2025 | Tremfya |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Arcutis Biotherapeutics, INC. | $87.37 | 2023 | |
| Novartis Pharmaceuticals Corporation | $68.03 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $66.99 | 2023-2025 | Ilumya |
| Ucb, INC. | $60.33 | 2024 | Bimzelx |
| Krystal Biotech INC | $41.87 | 2025 | Vyjuvek |
| Regeneron Healthcare Solutions, INC. | $35.77 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $31.81 | 2025 | Inspire |
| Genzyme Corporation | $30.87 | 2023 | |
| Electromed, INC. | $29.93 | 2025 | Smartvest |
| Inogen, INC. | $23.19 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $21.45 | 2024 | Sotyktu |
| Almirall LLC | $17.34 | 2025 | Klisyri |
| Lilly USA, LLC | $14.12 | 2025 | Taltz, Ebglyss |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.